Regional Anesthesia for Modified Radical Mastectomy With Axillary Lymph Node Dissection
- Conditions
- Breast Cancer
- Interventions
- Other: regional anesthesia
- Registration Number
- NCT04239716
- Lead Sponsor
- Tanta University
- Brief Summary
local and regional anesthesia have been introduced with the goal of reducing the side effects associated with general anesthesia and IV opioid analgesia.our hypothesis is that ultrasound-guided interscalene brachial plexus block and erector spinae plane block will provide efficient surgical anesthesia and postoperative analgesia after modified radical mastectomy.
- Detailed Description
inadequate analgesia after modified radical mastectomy with axillary lymph node dissection may occur with most of regional anesthesia. pain in the axilla and upper limb is related to ineffective block of medial and lateral pectoral nerves as long thoracic and thoracodorsal nerves, leading to inadequate analgesia.The aim of this study is to evaluate the efficacy and safety of ultrasound-guided interscalene brachial plexus block and erector spinae plane block for providing surgical anesthesia and postoperative analgesia after modified radical mastectomy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 13
- Female patients aged 40-85 years old
- American Society of Anesthesiologists' physical status III and IV
- Planned for modified radical mastectomy with axillary lymph node dissection
- Patient refusal
- Neurological or psychiatric disorders
- Local infection at injection site
- Spine or chest wall deformity
- Allergy or any contraindication to any of the study drugs
- Opioid or alcoholic addiction
- Chronic pain of any cause
- Uncooperative patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description regional anesthesia regional anesthesia combination of erector spinae plane block (ESPB) and interscalene block(IB).the ESPB will be performed using linear ultrasound transducer (Philips® cx 50 extreme edition, USA) and we will inject 20 ml solution(10 ml 0.5% bupivacaine, 5 ml 2% lidocaine, and 5 ml normal saline). the IB will be performed using the same ultrasound machine and injecting the same solution
- Primary Outcome Measures
Name Time Method Success rate of the regional blocks from the start to the end of the operation completion of the surgery without need of general anesthesia.
- Secondary Outcome Measures
Name Time Method Patients' satisfaction 24-hours postoperative degree of patients' satisfaction
duration of the blocks 24- hours in the postoperative period Time to first request of rescue analgesia postoperative
Any adverse events 24-hours postoperative postoperative nausea and vomiting, local anesthetic toxicity, desaturation, bradypnea,hypotension, bradycardia or somnolence
Trial Locations
- Locations (1)
Tanta University, Faculty of Medicine
🇪🇬Tanta, Egypt